Advertisement

Topics

Companies Related to "Revealing Identity Host Cell Proteins Better Drug Development" [Most Relevant Company Matches] RSS

05:25 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Revealing Identity Host Cell Proteins Better Drug Development" found in our extensive corporate database of over 50,000 company records.

Showing "Revealing Identity Host Cell Proteins Better Drug Development" Companies 1–25 of 9,200+

Relevant

PERCIVIA LLC

PERCIVIA LLC develops recombinant therapeutic proteins using the PER.C6® human cell line, with a focus on bio-better and bio-similar projects. PERCIVIA has developed a highly efficient protein production platform based on the PER.C6®cell line for the production of human therapeutic proteins with native human characteristics, at extremely high yields....


NewLab BioQuality AG

Our Services:„h Cell bank testing: characterisation of Master and Working Cell Bank and Post-Production-Cells„h DNA sequencing (GLP)„h Analysis and clearance validation on contaminants and impurities such as residual-DNA, proteins (HCP), Endotoxins, Mycoplasma, viruses and prions„h Characterisation of final product: identity, structure and stability testing„h Protein analysis„h bioassa...

Axxima Pharmaceuticals AG

Axximaâ„¢ Pharmaceuticals AG (formerly VirGene) is the leader in the application of pathogen-host signal transduction intervention. The company develops proprietary drugs that are based on Axxima's revolutionary approach to generate a Signal Transduction Firewallâ„¢ (STFâ„¢) against pathogens. Axxima's business strategy is to pursue the highly desirable area of anti-infective drug disc...


MultiCell Technologies

MultiCell Technologies, Inc. is an integrated biopharmaceutical company committed to the development of breakthrough therapeutics based on a portfolio of therapeutic candidates and patented drug development technologies. MultiCell’s drug development program is focused on the modulation of the immune system. The Company's lead drug candidates include drugs to treat MS-related chronic fatigue, rel...

Envoy Therapeutics, Inc.

Envoy Therapeutics’ mission is to discover new drugs with superior efficacy and fewer side effects than existing treatments. The company’s bacTRAP® technology enables the identification of proteins in vivo that are produced by specific cell types without requiring the isolation of those cells. The technology is especially powerful in tissues o...

Protalix Biotherapeutics, Inc.

Protalix is a biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins expressed through its proprietary plant cell based expression system. Protalix’s ProCellEx(TM) presents a proprietary method for the expression of recombinant proteins that Protalix believes will allow for the cost-e...

Sistemic Ltd.

Sistemic’s primary business is focused on providing innovative microRNA-based problem-solving services and kit-based products to areas of unmet need within Pharmaceutical, Biotechnology and the Cell Therapy research, development and manufacture markets. MicroRNAs are seen as the master controllers of a cell and as such Sistemic believe that they are p...

Envoy Therapeutics Inc.

Envoy Therapeutics’s mission is to discover new drugs with superior efficacy and fewer side effects than existing treatments. The company’s bacTRAP® technology enables the identification of proteins in vivo that are produced by specific cell types without requiring the isolation of those cells. The technology is especially powerful in tissues ...

Cell Essentials, Inc.

Cell Essentials provides contract cell biology-based services facilitating the creation of reagents for use in diagnostics and drug discovery as well as basic research. Major services include the development of custom hybridomas and production of monoclonal antibodies, large scale cell culture, stable cell line development, cell-based assay development, cell banking, and peptide synthesis. Adenovi...

Elsevier and Cell Press

Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the scientific community it serves. Cell Press primary research journals include the flagship journal Cell, as well as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, S...

Paradigm Therapeutics Incorporated

Paradigm Therapeutics is an emerging drug discovery company focussed on the pharmaceutical exploitation of the human genome. The race to define biological function of the thousands of uncharacterised human proteins is the new hallmark of modern drug discovery: Unlocking the physiology of novel proteins is a vital prerequisite to rational drug development on truly novel targets and the basis by on ...

Kinex Pharmaceuticals, LLC

Kinex Pharmaceuticals is developing next generation anti-cancer drugs that target the molecular basis of disease. The Company uses a proprietary technology platform to generate compounds that inhibit the Protein Kinase and Phosphatase family of proteins.Protein kinases and phosphatases are families of proteins that are intimately involved in transmitting signals across the cell membrane. They cont...

Shimoda Biotech (pty) Ltd

Shimoda Biotech (Proprietary) Limited ("Shimoda") is a leading South African biopharmaceutical discovery company that focuses on the development of innovative, proprietary drug delivery systems and novel therapeutic compounds. Shimoda's primary focus is on the development of proprietary drug delivery systems that enable the efficient delivery of drug molecules, proteins and genes to selected sites...

ID.me

ID.me is the next-generation digital identity platform that provides for trusted and convenient interactions between individuals and organizations. Government agencies and commercial partners use ID.me for online identity proofing and authentication to ensure their platforms and users are protected from fraud and identity theft.

Aeras Global TB Vaccine Foundation

ACE BioSciences is an emerging pharmaceutical company focused on developing novel, protein-based vaccines and antibodies to address infectious diseases caused by pathogens such as bacteria, fungi and viruses.ACE BioSciences' competitive advantage is founded on its unique expertise in the extraction and analysis of the cell surface proteins used by pathogens to interact with and infect human host c...

Princeton Identity Inc.

Princeton Identity offers the fastest, simplest and most secure biometric security system on the market. Leading the revolution toward a more intuitive, efficient and natural security experience that keeps people and business moving, Princeton Identity uses iris recognition and other biometric technology to enable businesses, governments and global organiz...

Cygnus Technologies, Inc

Technologies, Inc. provides the Biotechnology and Biopharmaceutical industry with products and analytical methods, designed to accelerate the R&D phase, improve process development and reduce the costs associated with labor intensive quality control procedures. We offer a comprehensive menu of well validated convenient to use microtiter plate ELISA methods to detect Host Cell Proteins from specif...

ScienCell Research Laboratories

ScienCell Research Laboratories (ScienCell) is a biotechnology company whose mission is the research and development of cell and cell-related products for experimental and therapeutic use. The ScienCell technology provides a variety of high quality normal human and animal cells, cell culture media and reagents, medium supplements, cell-derived RNA, cDNA and proteins for the research community. Sci...

PolyMedix Inc.

PolyMedix is a publicly traded emerging biotechnology company focused the development of novel drugs and biomaterials for the treatment of infectious diseases and acute cardiovascular disorders. PolyMedix’s compounds are based on biomimetics: non-peptide small molecule drug candidates that mimic the activity of proteins. The Company’s antibioti...

Identity Finder, LLC

Identity Finder, LLC, based in New York, NY, is the leader in sensitive data management. Its security and privacy technologies provide businesses and consumers the ability to prevent data leakage and identity theft.

HemoShear LLC

HemoShear LLC is a biotechnology research company that combines its scientific expertise with its unique technology in partnership with pharmaceutical companies to accelerate drug discovery and development. HemoShear has scientific expertise in the areas of human and animal biology, bioinformatics and molecular profiling for target identification and valid...

Ocugen, Inc.

Ocugen is advancing novel biologicals discovered based on endogenous proteins with well understood biology at the molecular, cellular, and whole animal level to treat eye diseases. The therapeutic proteins in the pipeline are derived from cell survival factors such as lens epithelium derived growth factor (LEDGF) and anti-angiogenic proteins such as tumsta...

PolyMedix, Inc.

PolyMedix is a publicly traded biotechnology company focused on the development of novel drugs and biomaterials for the treatment of serious acute cardiovascular disorders and infectious diseases. PolyMedix uses a rational drug design approach to create non-peptide small molecule drug candidates and polymers that mimic the activity of proteins. PMX-60056, ...

StemCells, Inc.

StemCells, Inc. is focused on the development and commercialization of cell-based technologies. In its cellular medicine programs, StemCells is targeting diseases of the central nervous system and liver. StemCells’ lead product candidate, HuCNS-SC® cells (purified human neural stem cells), is in clinical development for the treatment of two fatal n...

Consensus Pharmaceuticals Incorporated

Consensus Pharmaceuticals, Inc. is a functional proteomic and drug discovery company using several proprietary technologies to accelerate pharmaceutical research. The sequencing of the Human Genome has presented enormous commercial and scientific opportunities, as well as a massive new technical problem. While the industry now has the DNA sequences (Genomics) encoding tens of thousands of new prot...


More From BioPortfolio on "Revealing Identity Host Cell Proteins Better Drug Development"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks